Practical aspects in the management of hypokalemic periodic paralysis

Journal of Translational Medicine

Volumn 6, Issue , 2008, Pages

  Levitt, Jacob O ^a,b  

^a Periodic Paralysis Association   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; ALDOSTERONE ANTAGONIST; AMILORIDE; CARBONATE DEHYDRATASE INHIBITOR; CITRATE POTASSIUM; DICLOFENAMIDE; DIURETIC AGENT; EPLERENONE; GLUCONATE POTASSIUM; LIDOCAINE; MANNITOL; POTASSIUM BICARBONATE; POTASSIUM CHLORIDE; POTASSIUM ION; POTASSIUM SPARING DIURETIC AGENT; SODIUM; SPIRONOLACTONE; TRIAMTERENE; WATER; POTASSIUM;

ACUTE DISEASE; ARTICLE; BEHAVIOR THERAPY; BURNING SENSATION; CARBOHYDRATE DIET; CLINICAL PROTOCOL; COGNITIVE DEFECT; CONCENTRATION LOSS; CONFUSION; DIAGNOSTIC ACCURACY; DIARRHEA; DIET THERAPY; DISEASE SEVERITY; DRUG INDICATION; EXERCISE; GENETIC ANALYSIS; GYNECOMASTIA; HEART DISEASE; HUMAN; HYPOKALEMIC PERIODIC PARALYSIS; MAINTENANCE THERAPY; NEPHROLITHIASIS; OPTIMAL DRUG DOSE; PARALYSIS; PARESTHESIA; PERIOPERATIVE PERIOD; PREGNANCY; PRESCRIPTION; PROPHYLAXIS; REST; SOCIAL SUPPORT; STANDARD; SYMPTOM; TELEPHONE; WEAKNESS; DIET; DISEASE MANAGEMENT; FEMALE; PREGNANCY COMPLICATION; SELF HELP;

DIET; DISEASE MANAGEMENT; FEMALE; HUMANS; HYPOKALEMIC PERIODIC PARALYSIS; POTASSIUM; PREGNANCY; PREGNANCY COMPLICATIONS; SELF-HELP GROUPS;

EID: 43449103952     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-6-18     Document Type: Article

References (26)

1. Lehmann-Horn F Rudel R Jurkat-Rott K Non-dystrophic myotonias and periodic paralyses Myology New York: McGraw-Hill Engel AG 3 2004:1257-1300
2. Venance SL Jurkat-Rott K Lehmann-Horn F Tawil R SCN4A-associated hypokalemic periodic paralysis merits a trial of acetazolamide Neurology 2004, 63(10):1977. 15557532
3. Editorial Staff Potassium Supplements (Systemic) USP DI® Drug Information for the Health Care Professional Greenwood Village, Colorodo: Thomson Micromedex Klasco RK 26 2006 2483 90
4. Rose BD Clinical physiology of acid-base and electrolyte disorders New York: McGraw-Hill, Inc 4 1994:808-812
5. Griggs RC Resnick J Engel WK Intravenous treatment of hypokalemic periodic paralysis Arch Neurol 1983, 40(9):539-40. 6412669
6. Tawil R McDermott MP Brown R Jr Shapiro BC Ptacek LJ McManis PG Dalakas MC Spector SA Mendell JR Hahn AF Griggs RC Randomized trials of dichlorphenamide in the periodic paralyses. Working Group on Periodic Paralysis Ann Neurol 2000, 47(1):46-53. 10.1002/ 1531-8249(200001)47:1<46::AID-ANA9>3.0.CO;2-H 10632100
7. Tawil R Moxley RT 3rd Griggs RC Acetazolamide-induced nephrolithiasis: implications for treatment of neuromuscular disorders Neurology 1993, 43(6):1105-6. 8170551
8. Paisley KE Tomson CR Calcium phosphate stones during long-term acetazolamide treatment for epilepsy Postgrad Med J 1999, 75(885):427-8. 10474731
9. Liu Z Braverman LE Malabanan A Thyrotoxic periodic paralysis in a Hispanic man after the administration of prednisone Endocr Pract 2006, 12(4):427-431. 16901800
10. Gebhardt SE Thomas RG Nutritive Value in Foods Home and Garden Bulletin Number 72 Beltsville, Maryland: United States Department of Agriculture, Agricultural Research Service, Nutrient Data Laboratory http://www.nal.usda.gov/fnic/foodcomp/Data/HG72/hg72_2002.pdf Accessed June 10, 2006.
11. Monnier N Procaccio V Stieglitz P Lunardi J Malignant-hyperthermia susceptibility is associated with a mutation of the alpha 1-subunit of the human dihydropyridine-sensitive L-type voltage-dependent calcium-channel receptor in skeletal muscle Am J Hum Genet 1997, 60(6):1316-25. 1716149 9199552 10.1086/515454
12. Schapira AH Griggs RC eds Blue Books of Practical Neurology Muscle Diseases Boston: Butterworth-Heinemann 1999, 24:135-175
13. Marchant CL Ellis FR Halsall PJ Hopkins PM Robinson RL Mutation analysis of two patients with hypokalemic periodic paralysis and suspected malignant hyperthermia Muscle Nerve 2004, 30(1):114-7. 10.1002/mus.20068 15221887
14. Kim JB Kim MH Lee SJ Kim DJ Lee BC The genotype and clinical phenotype of korean patients with familial hypokalemic periodic paralysis J Korean Med Sci 2007, 22(6):946-51. 18162704
15. Robinson JE Morin VI Douglas MJ Wilson RD Familial hypokalemic periodic paralysis and Wolff-Perkinson-White syndrome in pregnancy Can J Anaesth 2000, 47(2):160-4. 10674511
16. Venance SL Cannon SC Fialho D Fontaine B Hanna MG Ptacek LJ Tristani-Firouzi M Tawil R Griggs RC CINCH investigators The primary periodic paralyses: Diagnosis, pathogenesis and treatment Brain 2006, 129:8-17. 10.1093/brain/awh639 16195244
17. Miller TM Dias da Silva MR Miller HA Kwiecinski H Mendell JR Tawil R McManis P Griggs RC Angelini C Servidei S Petajan J Dalakas MC Ranum LP Fu YH Ptácek LJ Correlating phenotype and genotype in the periodic paralyses Neurology 2004, 63(9):1647-1655. 15534250
18. Periodic Paralysis Association http://www.periodicparalysis.org [Accessed January 12, 2008]
19. Periodic Paralysis News Desk http://www.hkpp.org [Accessed January 12, 2008]
20. Muscular Dystrophy Association http://www.mdausa.org; [Accessed January 12, 2008]
21. Periodic Paralysis Association Research Registry http://www.pparesearch.org [Accessed January 12, 2008]
22. Heine R Pika U Lehmann-Horn F A novel SCN4A mutation causing myotonia aggravated by cold and potassium Hum Mol Genet 1993, 2(9):1349-1353. 10.1093/hmg/2.9.1349 8242056
23. Rudel R Lehmann-Horn F Paramyotonia, potassium-aggravated myotonias and periodic paralyses. 37th ENMC International Workshop, Naarden, The Netherlands, 8-10 December 1995 Neuromuscular Disord 1997, 7(2):127-132. 10.1016/S0960-8966(96)00418-X
24. Ricker K Moxley RT 3rd Heine R Lehmann-Horn F Myotonia fluctuans. A third type of muscle sodium channel disease Arch Neurol 1994, 51(11):1095-1102. 7980103
25. Ptacek LJ Tawil R Griggs RC Meola G McManis P Barohn RJ Mendell JR Harris C Spitzer R Santiago F Sodium channel mutations in acetazolamide-responsive myotonia congenita, paramyotonia congenita, and hyperkalemic periodic paralysis Neurology 1994, 44(8):1500-1503. 8058156
26. Lerche H Heine R Pika U George AL Jr Mitrovic N Browatzki M Weiss T Rivet-Bastide M Franke C Lomonaco M Human sodium channel myotonia: slowed channel inactivation due to substitutions for a glycine within the III-IV linker J Physiol 1993, 470:13-22. 1143902 8308722